HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GENFLEET-B

33.000

+3.42011.56%

Volume:5.46M

Turnover:175.06M

Market Cap:12.64B

PE:-5.44

High:33.400

Open:30.000

Low:29.560

Close:29.580

52wk High:52.900

52wk Low:19.600

Shares:383.00M

HK Float Shares:351.00M

Volume Ratio:1.54

T/O Rate:1.55%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-6.070

ROE:--

ROA:-19.54%

PB:6.73

PE(LYR):-5.44

PS:128.69

Loading ...

Overview Company News Filings

HK Movers | Pharma Stocks Jump With CanSino Biologics up 19%, Joinn Laboratories up 17%

Tiger Newspress

Movement Alert｜GENFLEET-B Rises 5.27% in Regular Trading, GFH375 Breakthrough Therapy Designation and Ongoing Buybacks Boost Sentiment

Ourea Biotech HK Limited Sells 6 Million Shares of GenFleet-B (02595) at HK$27.3 Each

GENFLEET-B: HL Partners II L.P. Disposes of Shares, Long Position Falls to 4.64%

GENFLEET-B: Ourea Biotech HK Limited Disposes of Shares, Long Position Falls to 4.64%

GENFLEET-B: HL GP II Company Limited Disposes of Shares, Long Position Falls to 4.64%

GENFLEET-B (02595) Shares Surge Nearly 8% in Early Trading; Investigational Oral Drug Proposed for Breakthrough Therapy Designation

Movement Alert｜GENFLEET-B Rises 7.59% in Regular Trading, Continuous Buybacks and Clinical Catalysts Drive Rebound

GenFleet Therapeutics Repurchases 116,000 H-Shares for HKD 3.19 Million, Lifts Treasury Stock to 988,000 Shares

Bulletin Express

GenFleet-B (02595) Spends HK$3.1855 Million to Repurchase 116,000 Shares on September 28

Movement Alert｜GENFLEET-B Falls 8.83% in Regular Trading, Prior BTD-Driven Rally Nearly Fully Retraced Amid Multiple Headwinds

GenFleet: Non-Executive Director Tao Sha Announces Resignation Effective 24 September 2026

Bulletin Express

GenFleet Therapeutics-B Director Tao Sha Steps Down from Non-Executive Role

GENFLEET-B (02595) Share Transfer Worth HK$912 Million, Accounting for 9.11%, with 24.59 Million Shares Moved Out of China Securities Depository and Clearing

GenFleet Hits over 3-Week High as Cancer Drug Makes Progress on BTD List

Genfleet-B Surges Over 9% Intraday As GFH375 Combination Therapy Moves Toward Breakthrough Therapy Designation

GenFleet to Unveil Early Clinical Results for KRAS G12D Inhibitor GFH375 and Pan-RAS Candidate GFH276; Investor Calls and ESMO Late-Breaking Abstract Confirmed

Bulletin Express

GENFLEET-B (02595) Outlines Schedule for Upcoming Clinical Data Presentations Concerning GFH375 and GFH276

GenFleet Schedules Oct. 15 Investor Call to Release Preliminary Gfh375-Cetuximab Trial Data in KRAS G12D Tumors

GenFleet Therapeutics (Shanghai) Says Gfh375 Combined with Cetuximab Placed on Proposed BTD List

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/02595/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02595","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"GENFLEET-B","latestPrice":33,"timestamp":1790755707004,"preClose":29.58,"halted":0,"volume":5456340,"delay":0,"changeRate":0.11561866125760656,"floatShares":351000000,"shares":383000000,"eps":-6.07,"marketStatus":"Closed National Day","change":3.42,"latestTime":"09-30 16:08:27","open":30,"high":33.4,"low":29.56,"amount":175060135,"amplitude":0.129817,"askPrice":33.1,"askSize":1200,"bidPrice":32.96,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.946,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":29.58,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":1.5425119892735373,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","floatShares":351000000,"roa":"-19.54%","roe":"--","lyrEps":-6.07,"volumeRatio":1.5425119892735373,"shares":383000000,"dividePrice":0,"high":33.4,"amplitude":0.129817,"preClose":29.58,"low":29.56,"week52Low":19.6,"pbRate":"6.73","psRate":"128.69","week52High":52.9,"institutionHeld":0,"latestPrice":33,"committee":-0.714286,"eps":-6.07,"divideRate":0,"volume":5456340,"delay":0,"ttmEps":-3.946,"open":30,"prevYearClose":23.78,"prevWeekClose":29.9,"prevMonthClose":33,"prevQuarterClose":33,"fiveDayClose":30.86,"twentyDayClose":28.3,"sixtyDayClose":32.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02595\",params:#limit:5,,,undefined,":[{"date":"2026-08-21","symbol":"02595","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787275800000,"name":null,"time":"","dateTimestamp":1787241600000,"actualEps":null},{"date":"2026-03-24","symbol":"02595","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774315800000,"name":null,"time":"","dateTimestamp":1774281600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02595\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02595\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1788105600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02595\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02595","date":"2026-09-29","current":-8.362899,"percent":0.772,"low":-19.62221,"twenty":-10.699678,"median":-9.072537,"eighty":-7.003679,"high":-5.69787,"avg":-9.275638,"sd":2.674082,"marketCap":10955444915},"quantilePoints":[{"date":"2025-09-19","current":-19.62221,"twenty":-19.62221,"median":-19.62221,"eighty":-19.62221,"marketCap":14538840523},{"date":"2025-09-26","current":-17.850791,"twenty":-18.989349,"median":-18.569255,"eighty":-18.336187,"marketCap":13192012066},{"date":"2025-10-03","current":-19.06699,"twenty":-19.162092,"median":-18.845312,"eighty":-18.417026,"marketCap":14124431767},{"date":"2025-10-10","current":-11.809112,"twenty":-19.045684,"median":-18.645404,"eighty":-16.087956,"marketCap":11948785798},{"date":"2025-10-17","current":-10.861917,"twenty":-19.006201,"median":-18.336187,"eighty":-11.374297,"marketCap":10981832034},{"date":"2025-10-24","current":-9.567304,"twenty":-18.816504,"median":-12.899451,"eighty":-10.554523,"marketCap":9676444452},{"date":"2025-10-31","current":-9.989391,"twenty":-18.681528,"median":-11.762498,"eighty":-10.081819,"marketCap":10118416331},{"date":"2025-11-07","current":-9.878556,"twenty":-18.646705,"median":-10.725216,"eighty":-9.89625,"marketCap":9999899010},{"date":"2025-11-14","current":-11.674836,"twenty":-18.558233,"median":-10.712517,"eighty":-9.936062,"marketCap":11851732160},{"date":"2025-11-21","current":-10.329745,"twenty":-18.396816,"median":-10.725216,"eighty":-10.005136,"marketCap":10481375629},{"date":"2025-11-28","current":-10.423287,"twenty":-18.142029,"median":-10.678396,"eighty":-10.044836,"marketCap":10614707615},{"date":"2025-12-05","current":-10.100425,"twenty":-16.087956,"median":-10.631034,"eighty":-10.044836,"marketCap":10303599646},{"date":"2025-12-12","current":-10.212238,"twenty":-13.008301,"median":-10.584309,"eighty":-10.020393,"marketCap":10436931633},{"date":"2025-12-19","current":-9.790532,"twenty":-12.136764,"median":-10.450758,"eighty":-9.957409,"marketCap":10029528340},{"date":"2025-12-24","current":-8.945585,"twenty":-11.809112,"median":-10.416014,"eighty":-9.900509,"marketCap":9192499756},{"date":"2026-01-02","current":-8.020182,"twenty":-11.73453,"median":-10.320373,"eighty":-9.861601,"marketCap":8273990514},{"date":"2026-01-09","current":-11.588563,"twenty":-11.683046,"median":-10.309663,"eighty":-9.776189,"marketCap":11985064146},{"date":"2026-01-16","current":-11.693807,"twenty":-11.67863,"median":-10.369243,"eighty":-9.793132,"marketCap":12133210798},{"date":"2026-01-23","current":-10.361602,"twenty":-11.605818,"median":-10.329745,"eighty":-9.783265,"marketCap":10740632270},{"date":"2026-01-30","current":-10.919089,"twenty":-11.483053,"median":-10.385171,"eighty":-9.793132,"marketCap":11370255541},{"date":"2026-02-06","current":-11.146899,"twenty":-11.598147,"median":-10.450758,"eighty":-9.8258,"marketCap":11636919514},{"date":"2026-02-13","current":-10.659945,"twenty":-11.483053,"median":-10.58187,"eighty":-9.869606,"marketCap":11192479558},{"date":"2026-02-20","current":-10.145441,"twenty":-11.446311,"median":-10.573435,"eighty":-9.881527,"marketCap":10636929613},{"date":"2026-02-27","current":-9.574146,"twenty":-11.38719,"median":-10.509847,"eighty":-9.836956,"marketCap":10148045662},{"date":"2026-03-06","current":-8.841756,"twenty":-11.29428,"median":-10.416014,"eighty":-9.744297,"marketCap":9296202413},{"date":"2026-03-13","current":-10.316011,"twenty":-11.38719,"median":-10.450758,"eighty":-9.761464,"marketCap":10896186254},{"date":"2026-03-20","current":-10.186272,"twenty":-11.29428,"median":-10.385171,"eighty":-9.744297,"marketCap":10718410272},{"date":"2026-03-27","current":-5.945762,"twenty":-11.270982,"median":-10.329745,"eighty":-9.723416,"marketCap":12081359470},{"date":"2026-04-02","current":-6.621163,"twenty":-11.205287,"median":-10.312136,"eighty":-9.574146,"marketCap":13518381995},{"date":"2026-04-10","current":-7.067323,"twenty":-11.18954,"median":-10.310332,"eighty":-9.547859,"marketCap":14540593893},{"date":"2026-04-17","current":-8.194366,"twenty":-11.170082,"median":-10.271344,"eighty":-9.114302,"marketCap":16866496330},{"date":"2026-04-24","current":-11.736244,"twenty":-11.170082,"median":-10.248784,"eighty":-8.950161,"marketCap":18318333519},{"date":"2026-04-30","current":-10.233962,"twenty":-11.173069,"median":-10.230093,"eighty":-8.995356,"marketCap":15977616418},{"date":"2026-05-08","current":-9.881779,"twenty":-11.158327,"median":-10.186272,"eighty":-9.095725,"marketCap":15481325134},{"date":"2026-05-15","current":-8.422278,"twenty":-11.148553,"median":-10.161068,"eighty":-8.948635,"marketCap":13229496023},{"date":"2026-05-22","current":-7.916926,"twenty":-11.098455,"median":-10.138144,"eighty":-8.800358,"marketCap":12407282105},{"date":"2026-05-29","current":-8.035507,"twenty":-11.019944,"median":-10.082937,"eighty":-8.624127,"marketCap":12636909415},{"date":"2026-06-05","current":-6.909175,"twenty":-10.994143,"median":-10.039967,"eighty":-8.441141,"marketCap":10881371589},{"date":"2026-06-12","current":-6.584396,"twenty":-10.981505,"median":-9.989391,"eighty":-8.291507,"marketCap":10362858307},{"date":"2026-06-18","current":-6.718884,"twenty":-10.969649,"median":-9.941921,"eighty":-8.193596,"marketCap":10599892950},{"date":"2026-06-26","current":-5.732708,"twenty":-10.937065,"median":-9.927249,"eighty":-8.035507,"marketCap":8999909109},{"date":"2026-07-03","current":-7.180567,"twenty":-10.922684,"median":-9.900616,"eighty":-7.915515,"marketCap":11281367549},{"date":"2026-07-10","current":-9.054005,"twenty":-10.894174,"median":-9.893411,"eighty":-7.915515,"marketCap":14207263926},{"date":"2026-07-17","current":-8.396292,"twenty":-10.887172,"median":-9.884317,"eighty":-7.956496,"marketCap":13222088691},{"date":"2026-07-24","current":-8.187485,"twenty":-10.884642,"median":-9.862553,"eighty":-8.009423,"marketCap":12896166056},{"date":"2026-07-31","current":-6.510345,"twenty":-10.870773,"median":-9.833804,"eighty":-7.907869,"marketCap":10273970316},{"date":"2026-08-07","current":-7.003679,"twenty":-10.846908,"median":-9.792157,"eighty":-7.575355,"marketCap":11073962237},{"date":"2026-08-14","current":-7.214728,"twenty":-10.805358,"median":-9.754197,"eighty":-7.296139,"marketCap":11422106869},{"date":"2026-08-21","current":-7.917767,"twenty":-10.771121,"median":-9.6954,"eighty":-7.255608,"marketCap":12562836089},{"date":"2026-08-28","current":-7.346545,"twenty":-10.748709,"median":-9.635917,"eighty":-7.293508,"marketCap":11659141512},{"date":"2026-09-04","current":-6.41515,"twenty":-10.730984,"median":-9.570725,"eighty":-7.1768,"marketCap":10185082325},{"date":"2026-09-11","current":-5.935917,"twenty":-10.723237,"median":-9.522333,"eighty":-7.102704,"marketCap":9436941732},{"date":"2026-09-18","current":-6.230255,"twenty":-10.708658,"median":-9.391188,"eighty":-7.03728,"marketCap":9592495717},{"date":"2026-09-25","current":-7.20619,"twenty":-10.699734,"median":-9.151454,"eighty":-7.03728,"marketCap":11073962237},{"date":"2026-09-29","current":-7.119176,"twenty":-10.699678,"median":-9.072537,"eighty":-7.003679,"marketCap":10955444915}],"updateTime":1790810634375},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02595\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1125539340","title":"HK Movers | Pharma Stocks Jump With CanSino Biologics up 19%, Joinn Laboratories up 17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125539340","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125539340?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:40","pubTimestamp":1790746819,"startTime":"0","endTime":"0","summary":"Hong Kong's biopharmaceutical sector rallied across the board, with $CANSINOBIO(06185)$ surging over 19%, $LAEKNA-B(02105)$ jumping more than 18%, and  $GENSCRIPT BIO(01548)$ rising nearly 9% to a new high. $EVEREST MED(01952)$ rose 6%, $XTALPI(02228)$ gained more than 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","06185","01276","06127","01548","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164899206","title":"Movement Alert｜GENFLEET-B Rises 5.27% in Regular Trading, GFH375 Breakthrough Therapy Designation and Ongoing Buybacks Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1164899206","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164899206?lang=en_us&edition=fundamental","pubTime":"2026-09-30 09:41","pubTimestamp":1790732510,"startTime":"0","endTime":"0","summary":"On September 30, GENFLEET-B rose 5.27% in regular trading, trading at HKD 31.3/share with turnover of HKD 13.76 million, extending the prior session's rebound momentum.On the news front, the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GENFLEET-B Rises on GFH375 Third BTD and Buyback Support","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198747120","title":"Ourea Biotech HK Limited Sells 6 Million Shares of GenFleet-B (02595) at HK$27.3 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1198747120","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198747120?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:28","pubTimestamp":1790681297,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 24, Ourea Biotech HK Limited reduced its holdings in GenFleet-B (02595) by 6 million shares at a price of HK$27.3 per...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","EWH","02595","BK4588","XBI","BK4581","09939","159938","BK4585","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188403712","title":"GENFLEET-B: HL Partners II L.P. Disposes of Shares, Long Position Falls to 4.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188403712","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188403712?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:41","pubTimestamp":1790674903,"startTime":"0","endTime":"0","summary":"On September 24, 2026, HL Partners II L.P. sold 6.00 million shares of GENFLEET-B on the SEHK open market at an average of HKD 27.3 per share, involving about HKD 163.80 million. The transaction was...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a44b570a4bc942c79569e09a943adc8c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133108978","title":"GENFLEET-B: Ourea Biotech HK Limited Disposes of Shares, Long Position Falls to 4.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133108978","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133108978?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:33","pubTimestamp":1790674434,"startTime":"0","endTime":"0","summary":"On September 24, 2026, Ourea Biotech HK Limited sold 6.00 million shares of GENFLEET-B on the SEHK open market at an average of HKD 27.3 per share, involving about HKD 163.80 million. This is an...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a44b570a4bc942c79569e09a943adc8c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168465401","title":"GENFLEET-B: HL GP II Company Limited Disposes of Shares, Long Position Falls to 4.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168465401","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168465401?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:14","pubTimestamp":1790673281,"startTime":"0","endTime":"0","summary":"On September 24, 2026, HL GP II Company Limited sold 6.00 million shares of GENFLEET-B on the SEHK open market at an average of HKD 27.30 per share, involving about HKD 163.80 million. This was an...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156162380","title":"GENFLEET-B (02595) Shares Surge Nearly 8% in Early Trading; Investigational Oral Drug Proposed for Breakthrough Therapy Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=1156162380","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156162380?lang=en_us&edition=fundamental","pubTime":"2026-09-29 11:31","pubTimestamp":1790652676,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) climbed nearly 8% in morning trading. As of press time, the stock was up 5.47% at HK$28.9, with turnover of HK$37.7862 million.On the news front, the company's self-developed oral...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","159938","VXUS","BK1161","09939","BK4588","BK1574","KCAI","BK4585","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155193986","title":"Movement Alert｜GENFLEET-B Rises 7.59% in Regular Trading, Continuous Buybacks and Clinical Catalysts Drive Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1155193986","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155193986?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:34","pubTimestamp":1790649298,"startTime":"0","endTime":"0","summary":"On September 29, GENFLEET-B rose 7.59% in regular trading, reaching HK$29.48 with turnover of approximately HK$27.11 million, recovering sharply from the prior session's 8.83% decline.On the news...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GENFLEET-B Jumps on Buybacks and Breakthrough Designation","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179781909","title":"GenFleet Therapeutics Repurchases 116,000 H-Shares for HKD 3.19 Million, Lifts Treasury Stock to 988,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1179781909","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179781909?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:01","pubTimestamp":1790589671,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) disclosed a share buyback executed on 28 September 2026 under its existing repurchase mandate approved on 11 May 2026. Key transaction details: •...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194011215","title":"GenFleet-B (02595) Spends HK$3.1855 Million to Repurchase 116,000 Shares on September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1194011215","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194011215?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:00","pubTimestamp":1790589620,"startTime":"0","endTime":"0","summary":"GenFleet-B (02595) has announced that on September 28, 2026, it spent HK$3.1855 million to repurchase 116,000 shares.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","BK1161","09939","BK1574","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146442081","title":"Movement Alert｜GENFLEET-B Falls 8.83% in Regular Trading, Prior BTD-Driven Rally Nearly Fully Retraced Amid Multiple Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=1146442081","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146442081?lang=en_us&edition=fundamental","pubTime":"2026-09-28 15:24","pubTimestamp":1790580277,"startTime":"0","endTime":"0","summary":"On September 28, GENFLEET-B declined 8.83% in regular trading to HKD 27.26, with turnover of approximately HKD 98.27 million. The drop nearly erased the gains triggered on September 23 when the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"GENFLEET-B Falls as BTD Rally Fades Amid 52% Revenue Drop","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147175695","title":"GenFleet: Non-Executive Director Tao Sha Announces Resignation Effective 24 September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1147175695","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147175695?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:44","pubTimestamp":1790239491,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. disclosed that Ms. Tao Sha has submitted her resignation as a non-executive director, effective 24 September 2026, citing personal work commitments. The company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192159357","title":"GenFleet Therapeutics-B Director Tao Sha Steps Down from Non-Executive Role","url":"https://stock-news.laohu8.com/highlight/detail?id=1192159357","media":"Stock News","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192159357?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:36","pubTimestamp":1790238979,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics-B (02595) has announced that Ms. Tao Sha has resigned from her position as a non-executive director due to personal work commitments.The resignation takes effect from September 24, 2026, according to the company's filing.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1515","09939","BK1574","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150493615","title":"GENFLEET-B (02595) Share Transfer Worth HK$912 Million, Accounting for 9.11%, with 24.59 Million Shares Moved Out of China Securities Depository and Clearing","url":"https://stock-news.laohu8.com/highlight/detail?id=1150493615","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150493615?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:34","pubTimestamp":1790210045,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange data shows that on September 23, GENFLEET-B (02595) saw a position change, with a total transfer value of HK$912 million, accounting for 9.11% of its shares. A shareholder...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","09939","BK1161","02595","161027","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669242179","title":"GenFleet Hits over 3-Week High as Cancer Drug Makes Progress on BTD List","url":"https://stock-news.laohu8.com/highlight/detail?id=2669242179","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669242179?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:20","pubTimestamp":1790130040,"startTime":"0","endTime":"0","summary":"BUZZ-GenFleet hits over 3-week high as cancer drug makes progress on BTD list** Shares of China-based innovative drugs developer GenFleet Therapeutics  Inc2595.HKjump 9.4% to HK$31.14, their highest level since August 31** GenFleet announces the regulatory progress related to the proposed inclusion of clinical program of a combination therapy for treatment of metastatic colorectal cancer into the Breakthrough Therapy Designation  list** Company says clinical program evaluatingGFH375 combined with cetuximabewas placed on the proposed BTD list by the Center for Drug Evaluation of China's National Medical Products Administration on September 18 while the public comment period will conclude on September 24** Company says it will release preliminary data from the study evaluating GFH375 in combination with cetuximab for the treatment of solid tumors on October 15, and its overseas partner Verastem Oncology will introduce the overseas clinical progress of GFH375/VS-7375 on October 14** YTD, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL1N45F025:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","VSTM","BANC","BK4139","02595","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131574006","title":"Genfleet-B Surges Over 9% Intraday As GFH375 Combination Therapy Moves Toward Breakthrough Therapy Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=1131574006","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131574006?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:20","pubTimestamp":1790130027,"startTime":"0","endTime":"0","summary":"Genfleet-B (02595) climbed more than 9% during Tuesday's trading session before paring gains, with shares last up 5.97% at HK$30.16 on turnover of HK$55.07 million.The company issued an announcement...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1574","09939","BK1515","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188673295","title":"GenFleet to Unveil Early Clinical Results for KRAS G12D Inhibitor GFH375 and Pan-RAS Candidate GFH276; Investor Calls and ESMO Late-Breaking Abstract Confirmed","url":"https://stock-news.laohu8.com/highlight/detail?id=1188673295","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188673295?lang=en_us&edition=fundamental","pubTime":"2026-09-23 08:20","pubTimestamp":1790122833,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) has outlined a detailed timetable for the first public release of clinical data from two of its lead RAS pathway assets, GFH375 and GFH276. GFH375...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157523117","title":"GENFLEET-B (02595) Outlines Schedule for Upcoming Clinical Data Presentations Concerning GFH375 and GFH276","url":"https://stock-news.laohu8.com/highlight/detail?id=1157523117","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157523117?lang=en_us&edition=fundamental","pubTime":"2026-09-23 08:10","pubTimestamp":1790122216,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has issued a corporate update detailing the timeline for sharing clinical study findings tied to its lead assets, GFH375 and GFH276. The company has scheduled an online investor...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","09939","BK1161","BK1574","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669040178","title":"GenFleet Schedules Oct. 15 Investor Call to Release Preliminary Gfh375-Cetuximab Trial Data in KRAS G12D Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669040178","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669040178?lang=en_us&edition=fundamental","pubTime":"2026-09-23 08:01","pubTimestamp":1790121670,"startTime":"0","endTime":"0","summary":"GenFleet schedules Oct. 15 investor call to release preliminary GFH375-cetuximab trial data in KRAS G12D tumorsGenFleet set October 15, 2026 for releasing preliminary study data on GFH375 combined wit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDLHpMS9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1161","BK4139","VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669192180","title":"GenFleet Therapeutics (Shanghai) Says Gfh375 Combined with Cetuximab Placed on Proposed BTD List","url":"https://stock-news.laohu8.com/highlight/detail?id=2669192180","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669192180?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:42","pubTimestamp":1790041368,"startTime":"0","endTime":"0","summary":"BRIEF-GenFleet Therapeutics  Says GFH375 Combined With Cetuximab Placed On Proposed BTD ListSept 22 -GenFleet Therapeutics  Inc2595.HK:GFH375 COMBINED WITH CETUXIMAB PLACED ON PROPOSED BREAKTHROUGH THERAPY DESIGNATION LIST BY NMPA ON SEP 18Further company coverage:2595.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45D0L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":131,"code":"91000000","status":"200"}]}}